Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis
Peng Wang(Sun Yat-sen University), Hai‐Feng Pan(Anhui Medical University), Guo‐Cui Wu(Anhui Medical University), Ya-ya Chu(Wannan Medical College), Ling-Qiong Jiang(Anhui Medical University), Jun He(University of South China), Fang Yang(Anhui Medical University), Guihong Wang(Anhui Provincial Hospital), Cong Chen(Anhui Medical University), Qingqing Chen(Fudan University), Yan Zhao(Anhui Medical University), Jing Ni(Anhui Medical University), De‐Guang Wang(Anhui Medical University), Ruo-Di Zhang(Anhui Medical University)
Cited by 14
Related Papers
Increased serum interleukin 17 in patients with systemic lupus erythematosus
|Molecular Biology Reports|2009|135
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges
|Autoimmunity Reviews|2022|99
Decreased serum IL-22 levels in patients with systemic lupus erythematosus
|Clinica Chimica Acta|2008|65
Mendelian randomization as a tool to gain insights into the mosaic causes of autoimmune diseases
|Autoimmunity Reviews|2022|55
Air pollution exposure and auto-inflammatory and autoimmune diseases of the musculoskeletal system: a review of epidemiologic and mechanistic evidence
|Environmental Geochemistry and Health|2023|30